Search results for: 'industrial grade na8e market'

This Frost & Sullivan annual outlook analyzes the medical devices industry across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. The study provides insights into market size, growth rates, opportunities, strategic imperatives, and macroeconomic trends shaping the medical devices industry. The study period spans 202...

This study focuses on the top 10 strategic imperatives impacting the MedTech industry in 2025. The industry includes the medical devices and medical imaging and informatics markets. Top transformations impacting industry growth include competitive intensity, compression of the value chain, industry convergence, transformative megatrends, internal...

In 2024, the life science (LS) industry s focus on precision health will intensify. LS companies will augment their omics-based research capabilities and increasingly deploy AI and bioinformatics to discover personalized therapies. Partnerships between pharmaceutical companies and technology vendors will multiply, to support innovation in drug disc...

Healthcare at home is emerging as one of the fastest-growing fields in modern medicine, driven by the rising demand for outpatient services, home-based monitoring, treatment, and rehabilitation. Increasing patient loads in clinics and hospitals have spurred federal initiatives that encourage the adoption of innovative solutions for decentralized ca...

This market insight provides data for the Global Opioid Therapeutics market. The analysis looks at opioid pharmaceutical pipeline drugs currently in the market and drugs that are in Phase III stage, which pose a potential threat to competitors. It also offers a competitive analysis of the drugs, and the forecast outcome and impact of each of these ...

Quantum sensing is transitioning from laboratory research to industrial deployment, driven by the need for ultra-precise, reliable measurement in high-impact sectors such as healthcare, defense, and advanced manufacturing. This shift reflects a broader move from controlled, research-grade environments toward scalable, field-ready systems that meet ...

This outlook identifies the trends shaping the global pharmaceutical landscape. The growth of the global pharmaceutical industry will plateau in 2023 due to a slowdown of the biologics segment as a result of a decrease in the uptake of COVID-19 vaccines and therapeutics. Market growth will be low in the United States and Europe and highest in the A...

This research service offers a comprehensive analysis of the global genetic testing industry (specifically, germline genetic testing, which analyzes inherited genetic variations present in an individual from birth and can be passed to offspring). The industry growth is driven by a shift towards preventive care, rising maternal ages, increasing gove...

With the growing preference for a patient-centric care delivery approach, the pharma industry follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market strategies. To cater to the ever-evolving market land...